Intestinal colonisation with carbapenemase producing enterobacteriaceae after foreign travel

Completed

• Conditions: intestinal bacteria; New Delhi metallo-beta-lactamase; 10004018

• Registration Number: NL-OMON35813
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-10-04
• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 521

Inclusion Criteria

All travellers planning a trip outside Europe are invited to participate in the study, aged 18 years and older.

Exclusion Criteria

Duration of travel longer than 3 months
Travelers carrying an ESBL-producing isolate before travel
Companion travellers are excluded in the study

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Cumulative incidences will be calculate by dividing the number of travellers<br /><br>diagnosted with a positive resistent Enterobacteriaceae by the number of<br /><br>travellers at risk per continent. The incidence rate of positive resistent<br /><br>Enterobacteriaceae will be calculate by dividing the number of travellers with<br /><br>a positive resistent Enterobacteriaceae by the total travel duration in person<br /><br>days. To determine risk factors for contracting a positive resistent<br /><br>Enterobacteriaceae, a logistic regression model will be used.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>